参考文献/References:
[1] ZIAEIAN B, FONAROW G C. Epidemiologyand aetiology of heart failure[J]. Nature ReviewsCardiology, 2016, 13(6): 368-378.
[2] RICH M W. Heart failure disease managementprograms: efficacy and limitations[J]. The AmericanJournal of Medicine, 2001, 110(5): 410-412.
[3] 贾昊,刘云鹏,屈欣怡,等.SERCA2a 在糖尿病心肌病中表达与调控研究进展[J]. 心肺血管病杂志,2018,37(2):165-168.JIA Hao, LIU Yunpeng, QU Xinyi, et al.The progressof SERCA2a expression and regulation in diabeticcardiomyopathy[J].Journal of Cardiovascular andPulmonary Diseases,2018,37(2):165-168.
[4] 吴锦波, 叶小汉, 冼绍祥, 等. 比索洛尔提高心力衰竭大鼠心肌SERCA2a 活性[J]. 基础医学与临床,2017,37(3):386-390.WU Jinbo,YE Xiaohan,XIAN Shaoxiang,et al.Bisoprolol increases myocardial SERCA2a activityin rats with heart failure[J]. Basic & ClinicalMedicine,2017,37(3):386-390.
[5] MATTILA M, KOSKENVUO J, S?DERSTR?M M, etal. Intramyocardial injection of SERCA2a-expressinglentivirus improves myocardial function in doxorubicininducedheart failure[J]. The Journal of Gene Medicine,2016, 18(7): 124-133.
[6] 屈慧,李娅,黄瑶楠,等.心力衰竭患者外周血RDW 和NT-pro-BNP 联合检测对临床诊断及分级的相关性研究[J].现代检验医学杂志,2020,35(5):65-67,72.QU Hui,LI Ya,HUANG Yaonan,et al. Correlationstudy on the combined detection of RDW and NT-Pro-BNP in patients with heart failure to clinical diagnosisand grading[J]. Journal of Modern LaboratoryMedicine,2020,35(5):65-67,72.
[7] ZHAI Yuting, LUO Yuanyuan, WU Pei, et al. Newinsights into SERCA2a gene therapy in heart failure:pay attention to the negative effects of B-typenatriuretic peptides[J]. Journal of Medical Genetics,2018, 55(5) : 287-296.
[8] SAKATA S, LEBECHE D, SAKATA N, et al.Restoration of mechanical and energetic function infailing aortic-banded rat hearts by gene transfer ofcalcium cycling proteins[J]. Journal of Molecular andCellular Cardiology, 2007, 42(4): 852-861.
[9] PIGNANI S, ZAPPATERRA F, BARBON E, etal. Tailoring the CRISPR system to transactivatecoagulation gene promoters in normal and mutatedcontexts[J]. Biochimica et Biophysica Acta-GeneRegulatory Mechanisms, 2019, 1862(6): 619-624.
[10] 马玉, 马先林. 川芎嗪对心血管的药理作用、临床应用及其效果分析[J]. 世界最新医学信息文摘,2019,19(30):213,219.MA Yu,MA Xianlin.Pharmacological action, clinicalapplication and effect analysis of Ligustrazine oncardiovascular system[J]. World Latest Medicine Information,2019,19(30):213,219.
[11] 季小勇.阿托伐他汀联合丹参川芎嗪治疗对冠心病伴高脂血症患者心功能及血脂的影响[J]. 血栓与止血学,2020,26(1):29-30,34.JI Xiaoyong. Effect of atorvastatin combined withDanshen and Ligustrazine on heart function andblood lipid in patients with coronary heart disease andhyperlipidemia [J]. Chinese Journal of Thrombosis andHemostasis,2020,26(1):29-30, 34.
[12] LIU Yanling, KONG Chunyan, SONG Peng, et al.Maslinic acid protects against pressure overloadinducedcardiac hypertrophy in mice[J]. Journal ofPharmacological Sciences, 2018, 138(2): 116-122.
[13] 全珺珺, 潘博, 贾忠莉, 等. 表没食子儿茶素没食子酸酯参与老年小鼠心脏SERCA2a 的调控及其机制[J]. 第三军医大学学报,2017,39(5):436-441.QUAN Junjun, PAN Bo, JIA Zhongli, et al. EGCGis involved in regulation of SERCA2a in agingmice hearts [J]. Journal of Third Military MedicalUniversity,2017,39(5):436-441.
[14] 浩日瓦, 娜日罕, 周红, 等. 血清microRNA126 和microRNA1 检测对心衰诊断价值的研究[J]. 现代检验医学杂志,2018,33(3):18-20,23.HAO Riwa,NA Rihan,ZHOU Hong,et al. Study on thediagnostic value of detecting serum microRNA126and microRNA1 in heart failure [J]. Journal of ModernLaboratory Medicine,2018,33(3):18-20,23.
[15] ALEXANIAN M, PADMANABHAN A, MCKINSEYT, et al. Epigenetic therapies in heart failure[J]. Journalof Molecular and Cellular Cardiology, 2019, 130: 197-204.
[16] 高婉琴, 李小丹, 杨朋康, 等. 血清Galectin-3 和sST2 水平检测用于保留射血分数心力衰竭的生物标记物的研究[J].现代检验医学杂志,2019,34(6):54-59.GAO Wanqin,LI Xiaodan,YANG Pengkang,et al.Study on Galectin-2 and sST2 used as biomarkerfor heart faliure patient with preserved ejectionfraction [J].Journal of Modern LaboratoryMedicine,2019,34(6):54-59.
[17] ZHAI Yuting, LUO Yuanyuan, WU Pei, et al. Newinsights into SERCA2a gene therapy in heart failure:pay attention to the negative effects of B-typenatriuretic peptides[J]. Journal of Medical Genetics,2018, 55(5): 287-296.
[18] 晏强, 周献青, 薛雯, 等. 表观遗传DNA 甲基化和组蛋白修饰与疾病关系的研究进展[J]. 医学综述,2017,23(16):3160-3163,3169.YAN Qiang,ZHOU Xianqing,XUE Wen,et al.Advances in the relationship between epigenetic DNAmethylation and histone modification with diseases[J].Medical Recapitulate,2017,23(16):3160-3163,3169.
[19] 张阳, 张志宇, 王辉, 等. 表观遗传学在心力衰竭中的最新研究进展[J]. 中国医学科学院学报, 2020, 42(1):103-107.ZHANG Yang,ZHANG Zhiyu,WANG Hui,et al.Recent advances of epigenetics in heart failure [J]. ActaAcademiae Medicinae Sinicae,2020,42(1):103-107.
[20] 张丽, 齐军, 吴宗勇, 等.耐碳青霉烯类肺炎克雷伯菌临床分离株中喹诺酮类及16SrRNA 甲基化酶基因的检测[J].现代检验医学杂志,2018,33(5):27-30.ZHANG Li,QI Jun,WU Zongyong,et al. Detectionof quinolone and 16SrRNA Methyltransferasegeneof clinical isolated carbapenem-resistant Klebsiellapneumoniae [J]. Journal of Modern LaboratoryMedicine, 2018,33(5):27-30.
[21] HELMSTADTER K G, LJUBOJEVIC-HOLZERS, WOOD B M, et al. CaMKII and PKA-dependentphosphorylation co-regulate nuclear localization ofHDAC4 in adult cardiomyocytes[J]. Basic Research inCardiology, 2021, 116(1): 11.